Article Details

Zacks Investment Research Downgrades CTI BioPharma (NASDAQ:CTIC) to Sell

Retrieved on: 2020-12-23 01:18:45

Tags for this article:

Click the tags to see associated articles and topics

Zacks Investment Research Downgrades CTI BioPharma (NASDAQ:CTIC) to Sell. View article details on hiswai:

Excerpt

According to Zacks, "CTI BioPharma Corp. is a biopharmaceutical company. It is focused on the acquisition, development and commercialization of ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo